(BRM) BioRem - Ratings and Ratios
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA09068G1046
BRM: Biofilters, Biotrickling Filters, Air Filtration
BioRem Inc. (V:BRM) is a clean technology engineering firm specializing in the design, manufacture, distribution, and sale of advanced air pollution control systems. These systems are engineered to effectively eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs) across various industrial and commercial applications. The companys product portfolio includes biofilters, biotrickling filters, multi-stage synergy systems, biogas desulfurization systems, dry scrubber adsorption systems, and cannabis odor control systems. Its solutions are marketed under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK brands. With operations spanning Canada, the United States, China, and other international markets, BioRem Inc. has established itself as a key player in the air pollution control sector. Founded in 1990, the company is headquartered in Puslinch, Canada, and is recognized for its expertise in delivering environmentally friendly and cost-effective solutions to industrial emissions challenges.
Based on the provided data, here is a 3-month forecast for BioRem Inc. (V:BRM):
Additional Sources for BRM Stock
BRM Stock Overview
Market Cap in USD | 33m |
Sector | Industrials |
Industry | Pollution & Treatment Controls |
GiC Sub-Industry | Industrial Machinery & Supplies & Components |
IPO / Inception |
BRM Stock Ratings
Growth 5y | 90.9% |
Fundamental | 75.0% |
Dividend | 0.0% |
Rel. Strength | 45.4 |
Analysts | - |
Fair Price Momentum | 2.46 CAD |
Fair Price DCF | 7.56 CAD |
BRM Dividends
No Dividends PaidBRM Growth Ratios
Growth Correlation 3m | -88.8% |
Growth Correlation 12m | 73.8% |
Growth Correlation 5y | 94.1% |
CAGR 5y | 43.10% |
CAGR/Max DD 5y | 1.04 |
Sharpe Ratio 12m | -0.99 |
Alpha | 4.34 |
Beta | 0.851 |
Volatility | 133.56% |
Current Volume | 90.1k |
Average Volume 20d | 27.7k |
As of April 11, 2025, the stock is trading at CAD 2.10 with a total of 90,076 shares traded.
Over the past week, the price has changed by -8.70%, over one month by -16.00%, over three months by -31.60% and over the past year by +46.85%.
Yes, based on ValueRay Fundamental Analyses, BioRem (V:BRM) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 75.01 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BRM as of April 2025 is 2.46. This means that BRM is currently undervalued and has a potential upside of +17.14% (Margin of Safety).
BioRem has no consensus analysts rating.
According to ValueRays Forecast Model, BRM BioRem will be worth about 2.7 in April 2026. The stock is currently trading at 2.10. This means that the stock has a potential upside of +29.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 2.7 | 29% |